• July 25, 2026 |
  • Science

American Diabetes Association Faces Backlash After Removing Scientists

The expulsion of five prominent researchers from a major conference has ignited a debate over scientific autonomy and the role of professional organizations in policy advocacy.

by James Radley |
SHARE
Illustration by John Doe

The American Diabetes Association (ADA) faced intense scrutiny following the removal of five prominent diabetes researchers from its annual scientific sessions in New Orleans on June 5, 2026. Security personnel and local police escorted the scientists from the Ernest N. Morial Convention Center after they distributed an editorial criticizing federal biomedical research funding cuts.

Justin Ryder, a researcher at Northwestern University and Lurie Children’s Hospital of Chicago, reported that security staff became physically aggressive when he refused to cease the distribution of the document. The editorial, titled “Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States,” appeared in the ADA journal Diabetes Care. Steven Kahn, a University of Washington specialist and editor-in-chief of the journal, co-authored the piece and was among those removed from the premises. Other researchers involved in the incident included Aaron Kelly, Desmond Schatz, and Irl Hirsch, all of whom hold significant standing within the clinical and research community.

ADA officials maintained that the removal was a procedural enforcement of the organization’s code of conduct rather than a suppression of the editorial’s content. The association requires prior approval for the distribution of materials and restricts such activities to designated exhibit hall areas. A spokesperson for the ADA stated that the attendees were given multiple opportunities to comply with these rules before security intervention occurred. Despite this explanation, the incident drew immediate condemnation from across the scientific community, with many observers characterizing the move as an act of censorship.

The fallout from the event was swift and significant, leading to the resignations of Mark Atkinson, the conference scientific sessions chair at the University of Florida, and Jennifer Green, the ADA’s president-elect at Duke University. Jay Bhattacharya, the then-director of the National Institutes of Health, also withdrew from his scheduled keynote address following the controversy. The incident sparked a widespread petition demanding a formal apology and prompted intense debate on social media platforms regarding the limits of free expression at professional scientific gatherings.

On June 10, 2026, ADA CEO Charles Henderson issued a video statement apologizing to the affected members for the escalation of the situation. Henderson announced that the organization would conduct an internal review of its policies to prevent similar occurrences in the future. He emphasized the ADA’s commitment to maintaining a nonpartisan stance, citing the necessity of protecting the group’s tax-exempt status as a nonprofit entity. These assurances failed to quell the criticism from senior figures in the field who argued that the aggressive response damaged the organization’s credibility.

The controversy highlights a growing tension between the administrative requirements of professional societies and the desire of researchers to engage in public policy discourse. Observers note that the editorial itself, which underwent peer review before publication in an ADA-affiliated journal, warned of the long-term risks that federal budget shifts pose to innovation and patient care. By attempting to restrict the circulation of these concerns, the ADA inadvertently drew greater attention to the arguments presented by the researchers. The incident has left a lasting impact on the relationship between the association and its research base, prompting other professional societies to re-evaluate their own protocols for handling dissent.

The broader implications of this event extend to the future of scientific advocacy in the United States. As federal funding for biomedical research remains a point of contention, the ability of researchers to speak openly about the impact of policy decisions on their work is increasingly viewed as a critical component of scientific integrity. The ADA’s internal review may lead to procedural adjustments, but the loss of trust among key stakeholders suggests that the path toward reconciliation will be complex. The scientific community continues to monitor how the organization will address these concerns as it prepares for future conferences.

More from Science

Home » American Diabetes Association Faces Backlash After Removing Scientists
Join our newsletter
Stay up to date on latest stories
© Hampton Global 2026.
Join our newsletter
Stay up to date on latest stories